Bringing the fundamentals into focus…
Back to Perrigo Company plc
How Perrigo Company plc stacks up
PRGO · against 392 other Healthcare companies of similar size
Valuation
62/ 100
Above the middle of the pack.
Ranked #162 of 393 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score44 peers with a valuation score of 60–69, including PRGO · Click a bar to see the companies
Why valuation scores 62?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its EBITDA yield and free cash flow yield, which are stronger than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -78.3% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 82% of peers. Free cash flow yield: 5.5% vs peer median 0.0%
- more operating profit (EBITDA) for the company's total value: stronger than 85% of peers. EBITDA yield: 11.6% vs peer median 4.0%
Metric by metric
Position: dot = PRGO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | PRGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 382 reported | -78.3% | 1.7% | 0% | 30% | |
| EBITDA yieldHigher is better · 393 reported | 11.6% | 4.3% | 86% | 50% | |
| Free cash flow yieldHigher is better · 193 reported | 5.5% | -0.5% | 79% | 20% | |
| Book yieldHigher is better · 384 reported | 115.5% | 34.1% | 96% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around PRGOScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score